Literature DB >> 20836050

APOBEC-1-mediated RNA editing.

Valerie Blanc1, Nicholas O Davidson1.   

Abstract

RNA editing defines a molecular process by which a nucleotide sequence is modified in the RNA transcript and results in an amino acid change in the recoded message from that specified in the gene. We will restrict our attention to the type of RNA editing peculiar to mammals, i.e., nuclear C to U RNA editing. This category of RNA editing contrasts with RNA modifications described in plants, i.e., organellar RNA editing (reviewed in Ref 1). Mammalian RNA editing is genetically and biochemically classified into two groups, namely insertion-deletional and substitutional. Substitutional RNA editing is exclusive to mammals, again with two types reported, namely adenosine to inosine and cytosine to uracil (C to U). This review will examine mammalian C to U RNA editing of apolipoproteinB (apoB) RNA and the role of the catalytic deaminase Apobec-1. We will speculate on the functions of Apobec-1 beyond C to U RNA editing as implied from its ability to bind AU-rich RNAs and discuss evidence that dysregulation of Apobec-1 expression might be associated with carcinogenesis through aberrant RNA editing or altered RNA stability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20836050      PMCID: PMC3086428          DOI: 10.1002/wsbm.82

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Syst Biol Med        ISSN: 1939-005X


  71 in total

1.  Gene expression during preimplantation mouse development.

Authors:  J L Rothstein; D Johnson; J A DeLoia; J Skowronski; D Solter; B Knowles
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

2.  Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues.

Authors:  B Teng; M Verp; J Salomon; N O Davidson
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

3.  Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression.

Authors:  Shrikant Anant; Nabendu Murmu; Courtney W Houchen; Debnath Mukhopadhyay; Terrence E Riehl; Stephen G Young; Aubrey R Morrison; William F Stenson; Nicholas O Davidson
Journal:  Gastroenterology       Date:  2004-10       Impact factor: 22.682

4.  Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation.

Authors:  P P Lau; W J Xiong; H J Zhu; S H Chen; L Chan
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

5.  Sequence requirements for the editing of apolipoprotein B mRNA.

Authors:  R R Shah; T J Knott; J E Legros; N Navaratnam; J C Greeve; J Scott
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

6.  Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins.

Authors:  S G Harris; I Sabio; E Mayer; M F Steinberg; J W Backus; J D Sparks; C E Sparks; H C Smith
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

7.  Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.

Authors:  Mark P Sowden; David M Lehmann; Xiaoyan Lin; Charles O Smith; Harold C Smith
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

8.  Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro.

Authors:  J W Backus; H C Smith
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

9.  Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA.

Authors:  D M Driscoll; S Lakhe-Reddy; L M Oleksa; D Martinez
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

10.  Molecular cloning of an apolipoprotein B messenger RNA editing protein.

Authors:  B Teng; C F Burant; N O Davidson
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

View more
  57 in total

1.  Injury-dependent Müller glia and ganglion cell reprogramming during tissue regeneration requires Apobec2a and Apobec2b.

Authors:  Curtis Powell; Fairouz Elsaeidi; Daniel Goldman
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

Review 2.  RNA modifications and structures cooperate to guide RNA-protein interactions.

Authors:  Cole J T Lewis; Tao Pan; Auinash Kalsotra
Journal:  Nat Rev Mol Cell Biol       Date:  2017-02-01       Impact factor: 94.444

Review 3.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

Review 4.  Parallel Evolution and Lineage-Specific Expansion of RNA Editing in Ctenophores.

Authors:  Andrea B Kohn; Rachel S Sanford; Masa-aki Yoshida; Leonid L Moroz
Journal:  Integr Comp Biol       Date:  2015-06-18       Impact factor: 3.326

Review 5.  Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.

Authors:  Hong-Xia Zhang; Ying Zhang; Hao Yin
Journal:  Mol Ther       Date:  2019-01-25       Impact factor: 11.454

Review 6.  Mechanisms of DNA damage, repair, and mutagenesis.

Authors:  Nimrat Chatterjee; Graham C Walker
Journal:  Environ Mol Mutagen       Date:  2017-05-09       Impact factor: 3.216

7.  APOBEC3B and AID have similar nuclear import mechanisms.

Authors:  Lela Lackey; Zachary L Demorest; Allison M Land; Judd F Hultquist; William L Brown; Reuben S Harris
Journal:  J Mol Biol       Date:  2012-03-23       Impact factor: 5.469

8.  C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.

Authors:  Nicolas Fossat; Karin Tourle; Tania Radziewic; Kristen Barratt; Doreen Liebhold; Joshua B Studdert; Melinda Power; Vanessa Jones; David A F Loebel; Patrick P L Tam
Journal:  EMBO Rep       Date:  2014-06-10       Impact factor: 8.807

9.  Unusual noncanonical intron editing is important for tRNA splicing in Trypanosoma brucei.

Authors:  Mary Anne T Rubio; Zdeněk Paris; Kirk W Gaston; Ian M C Fleming; Paul Sample; Christopher R Trotta; Juan D Alfonzo
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

Review 10.  U-Insertion/Deletion mRNA-Editing Holoenzyme: Definition in Sight.

Authors:  Inna Aphasizheva; Ruslan Aphasizhev
Journal:  Trends Parasitol       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.